| DIRECT COMPETITOR COMPARISON | |
| CAPS | ECOL | SRCL | STE | Industry | | Market Cap: | 27.32M | 309.28M | 4.79B | 1.71B | 98.96M | | Employees: | 26 | 253 | 6,567 | 5,000 | 68 | | Qtrly Rev Growth (yoy): | N/A | -8.60% | 7.50% | -2.80% | 19.70% | | Revenue (ttm): | N/A | 152.91M | 1.14B | 1.26B | 14.01M | | Gross Margin (ttm): | N/A | 26.84% | 46.78% | 41.33% | 65.67% | | EBITDA (ttm): | -14.54M | 35.31M | 349.54M | 248.52M | -12.30M | | Oper Margins (ttm): | N/A | 17.53% | 27.43% | 15.18% | -137.11% | | Net Income (ttm): | -13.24M | 16.58M | 170.21M | 113.98M | N/A | | EPS (ttm): | -0.325 | 0.911 | 1.956 | 1.927 | -0.33 | | P/E (ttm): | N/A | 18.70 | 29.10 | 15.12 | 17.26 | | PEG (5 yr expected): | N/A | 1.02 | 1.6 | 0.98 | 1.28 | | P/S (ttm): | N/A | 2.02 | 4.21 | 1.36 | 9.45 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.85 | 0.00% | 57.54B | 12.40 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 48.18 | 0.00% | 13.93B | 16.12 | | Genzyme Corp. | GENZ | 49.98 | 0.00% | 13.26B | 28.49 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.59 | 0.00% | 41.93B | 18.02 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 50.64 | 0.00% | 9.03B | 1033.47 | | Teva Pharmaceutical Industries Limited | TEVA | 54.01 | 0.00% | 47.58B | 49.41 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.90 | 0.00% | 4.02B | 19.54 | | King Pharmaceuticals Inc. | KG | 11.72 | 0.00% | 2.91B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.99 | 0.00% | 5.50B | 110.37 | | Pfizer Inc. | PFE | 18.49 | 0.00% | 149.21B | 15.36 | | Johnson & Johnson | JNJ | 64.36 | 0.00% | 177.58B | 14.06 | | GlaxoSmithKline plc | GSK | 42.75 | 0.00% | 108.37B | 13.49 | | Sanofi-Aventis | SNY | 39.38 | 0.00% | 102.83B | N/A | | Novartis AG | NVS | 55.55 | 0.00% | 126.17B | 16.63 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 41.42 | 0.00% | N/A | N/A | | AstraZeneca plc | AZN | 46.30 | 0.00% | 67.13B | 9.30 | | Abbott Laboratories | ABT | 53.78 | 0.00% | 83.18B | 14.57 | | Bristol-Myers Squibb Co. | BMY | 25.14 | 0.00% | 49.80B | 13.01 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | STE | | STERIS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Mon 6:02am -
EDGAR Online | | • | STE | | F.D.A. Warns of Problems With Sterilization Device
Sat, Dec 5 -
at The New York Times | | • | STE | | Shares of Steris Corp. Plunge on FDA Notice
Fri, Dec 4 -
at Fox Business | | • | STE | | Monster, DuPont, Take-Two are big movers
Fri, Dec 4 -
AP | | • | STE | | STERIS Statement in Response to December 3, 2009 FDA Notice and Developments On SYSTEM 1 Warning Letter
Fri, Dec 4 -
Business Wire | | • | ECOL | | Better Buy: Waste Management or Republic Services?
Thu, Dec 3 -
at Motley Fool | | • | SRCL | | Nebraska attorney general lauds merger agreement
Wed, Dec 2 -
AP | | • | SRCL | | Suit, settlement would force MedServe to sell Kansas City, Kan., facility
Tue, Dec 1 -
at bizjournals.com | | • | SRCL | | Stericycle gets US approval for MedServe deal
Mon, Nov 30 -
AP | | • | SRCL | | Stericycle, Inc. Receives Clearance to Acquire MedServe, Inc.
Mon, Nov 30 -
Business Wire | | • | ECOL | | Bearish MACD for American Ecology
Wed, Nov 18 -
Zacks.com | | • | ECOL | | Nuclear Is the Way to Invest in Clean Energy
Tue, Nov 17 -
at The Wall Street Journal Online | | • | ECOL | | RINO Jacks Up the Pollution Control Stocks Index
Fri, Nov 13 -
Indie Research | | • | SRCL | | STERICYCLE INC Financials
Fri, Nov 13 -
EDGAR Online Financials | | • | ECOL | | Nuclear Is Next Big Power Play
Thu, Nov 12 -
at The Wall Street Journal Online | | • | ECOL | | AMERICAN ECOLOGY CORP Financials
Tue, Nov 3 -
EDGAR Online Financials | | • | ECOL | | American Ecology: Turning Trash Into Cash
Fri, Oct 30 -
at Seeking Alpha | | • | ECOL | | AMERICAN ECOLOGY CORP Files SEC form 10-Q, Quarterly Report
Thu, Oct 29 -
EDGAR Online | | • | ECOL | | Stericycle Beats Zacks Estimate
Thu, Oct 29 -
Zacks.com | | • | ECOL | | American Ecology Corp. downgraded by Canaccord Adams
Wed, Oct 28 -
Briefing.com | | | All Headlines for these symbols... |
|
|
|
0.22% Nasdaq 0.00%
Competitors
